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Renal Oxygenation in the
Pathophysiology of Chronic Kidney
Disease
Zhi Zhao Liu, Alexander Bullen, Ying Li and Prabhleen Singh*
Division of Nephrology-Hypertension, University of California San Diego School of Medicine, VA San Diego Healthcare
System, San Diego, CA, United States
Chronic kidney disease (CKD) is a significant health problem associated with high
morbidity and mortality. Despite significant research into various pathways involved
in the pathophysiology of CKD, the therapeutic options are limited in diabetes and
hypertension induced CKD to blood pressure control, hyperglycemia management
(in diabetic nephropathy) and reduction of proteinuria, mainly with renin-angiotensin
blockade therapy. Recently, renal oxygenation in pathophysiology of CKD progression
has received a lot of interest. Several advances have been made in our understanding
of the determinants and regulators of renal oxygenation in normal and diseased kidneys.
The goal of this review is to discuss the alterations in renal oxygenation (delivery,
consumption and tissue oxygen tension) in pre-clinical and clinical studies in diabetic
and hypertensive CKD along with the underlying mechanisms and potential therapeutic
options.
Keywords: hypoxia, renal oxygen consumption, hypoxia inducible factor (HIF), AMPK, chronic kidney disease
pathophysiology
INTRODUCTION
Chronic kidney disease (CKD) is a worldwide public health problem. In the United States, 14%
of adults suffer from CKD (Coresh et al., 2007). Besides its impact on health, CKD and end-stage
renal disease (ESRD) require substantial healthcare resources (Honeycutt et al., 2013). Despite the
resources committed to the treatment of CKD and improvements in the quality of dialysis therapy,
CKD patients continue to experience significant mortality and morbidity and a reduced quality
of life. Numerous studies have elucidated the underlying mechanisms of CKD and identified new
therapeutic targets, but success in clinical translation has been limited. Among various pathways,
imbalance between oxygen delivery and consumption leading to tissue hypoxia has been recognized
as an important contributor to CKD development and progression (Fine et al., 1998; Norman and
Fine, 2006; O’Connor, 2006; Mimura and Nangaku, 2010). The aim of this review is to discuss
the role of renal oxygenation (oxygen delivery, consumption and tissue oxygen tension) in CKD
progression and potential therapeutic options based on recent literature.
TUBULAR TRANSPORT
The major function of kidney is to remove waste products and excess fluid from the body to
maintain homeostasis. The kidneys filter about 180 liters of fluid daily. Nearly 99% of the of filtered
sodium is reabsorbed and this is the primary energy consuming process in the kidneys powered
Liu et al. Renal Oxygenation in CKD
by the Na- and K-ATPase (sodium-potassium pump) in the
basolateral membranes of tubular cells in the kidney. About 60–
70% of total sodium reabsorption takes place in the proximal
tubule, and another 25–30% in the thick ascending limb of
the loop of Henle, and less than 10% in the distal convoluted
tubule and collecting duct (Palmer and Schnermann, 2015). The
sodium-potassium pump transports three sodium atoms out of
the cell and two potassium atoms into the cell with the cost of
hydrolyzing one ATP molecule (Mandel and Balaban, 1981). To
retrieve nearly 99% of filtered Na, a continuously large amount of
ATP (>1.7× 1024 molecules) is required.
RENAL OXYGENATION
Both oxidative and glycolytic pathways produce ATP. Compared
to 2 molecules of ATP production in glycolysis per molecule of
glucose, oxidative phosphorylation, generating 30–36 molecules
of ATP, is more efficient (Soltoff, 1986). Hence, sufficient oxygen
delivery to the kidney is needed to generate the required ATP
via mitochondrial oxidative phosphorylation. Renal blood flow
in the kidney is inhomogeneous, with cortex being well-perfused,
but only 10–15% of perfusion directed to medulla to preserve
osmotic gradients and enhance urinary concentration (Chou
et al., 1990). Moreover, the arterial-to-venous oxygen shunting
in medulla, which results from a counter-current exchange of
oxygen before arterial blood reaches the renal microcirculation,
decreases oxygen availability in this region (Evans et al., 2008).
Lastly, the high metabolic requirements of the thick ascending
limbs also contribute to hypoxia particularly in the outer
medullary region, where the transport-related oxygen demand
is high, while the delivery is lower than the cortex (Aukland
and Krog, 1960; Mandel and Balaban, 1981; O’Connor, 2006).
These particular features of tubular transport and metabolism
can aggravate outer medullary hypoxia.
There is a close relation between GFR, renal sodium
reabsorption, and oxygen consumption (Kiil et al., 1961; Blantz
et al., 2007). In most organs, an increased demand of oxygen
is met by an increased blood flow to increase oxygen delivery.
However, an increase in blood flow to the kidney results in a
simultaneously increased tubular sodium load due to increased
GFR. Since sodium reabsorption is the major determinant of
renal oxygen consumption (Lassen et al., 1961; Torelli et al.,
1966), increased renal blood flow besides increasing oxygen
supply also increases oxygen demand attributed to increased
reabsorptive sodium load. It has been shown that renal oxygen
extraction remains stable over a wide range of renal blood
flow (Levy, 1960), indicating the increased oxygen delivery by
renal blood flow is directly counteracted by increased oxygen
consumption. So, maneuvers that increase GFR and thus the
tubular sodium load also increase oxygen consumption and the
effect on renal oxygenation is not always predictable.
RENAL OXYGENATION IN DIABETIC CKD
According to the data from National Institute of Diabetes
and Digestive and Kidney Diseases, as of 2014, nearly 10% of
the US population has diabetes (Diabetes-NIDDK1). Diabetic
nephropathy develops in nearly 40% of patients with diabetes
and is the leading cause of CKD in patients with ESRD
(Reutens, 2013). There has been significant advances in our
understanding of the various pathways in the pathogenesis of
diabetic nephropathy: hyperglycemia, glomerular hyperfiltration,
activation of the polyol, renin-angiotensin and the protein kinase
C pathways, advanced glycation end products, and genetic
susceptibility (Brownlee, 2005). However, clinical translation
to successful therapeutics for diabetic nephropathy has been
limited. Since Fine et al. proposed kidney hypoxia as a mediator
of progressive kidney disease (Fine et al., 1998), numerous
experimental and clinical studies have provided evidence in
support of chronic hypoxia being a common pathway for various
progressive kidney diseases including diabetic nephropathy
(Nangaku, 2006; Palm, 2006; Singh et al., 2008a, 2013; Mimura
and Nangaku, 2010; Palm and Nordquist, 2011).
In experimental streptozotocin-induced diabetes, Ries et al.
demonstrated that hypoxia was present in all compartments of
the diabetic kidney, particularly in the outer medulla, using blood
oxygen level-dependent (BOLD) MRI and diffusion-weighted
imaging (Ries et al., 2003). Palm et al. showed a decrease
in renal oxygen tension in the diabetic kidney, particular in
medulla, due to the augmented oxygen consumption (Palm
et al., 2003). Intrarenal microcirculation was not changed, but
deoxyhemoglobin signals rose in diabetic kidney and oxygen
consumption by tubular cells was significantly enhanced (Palm
et al., 2003, 2004). Later the same group confirmed their findings
using BOLD imaging (Edlund et al., 2009). Another study,
demonstrated that hypoxic changes can be detected as early as 2
days in the diabetic kidney (dos Santos et al., 2007). Subsequently,
Rosenberger et al. provided information on cellular localization
of hypoxia in thick ascending limbs and a lesser extent in
the collecting ducts using immunohistochemical staining with
pimonidazole, a molecular hypoxia probe, and hypoxia inducible
factor (HIF) (Rosenberger et al., 2008).
Recent studies have demonstrated the presence of tissue
hypoxia before the presence of markers of kidney injury in
diabetes. Friederich-Persson et al. reported kidney hypoxia
resulting from increased mitochondrial oxygen consumption,
independent of hyperglycemia and oxidative stress, was
associated with tubulointerstitial damage, proteinuria and
infiltration of inflammatory cells (Friederich-Persson et al.,
2013). They concluded that kidney tissue hypoxia, per se, may
be sufficient to initiate the development of nephropathy. Others
have demonstrated the presence of tissue hypoxia in the kidney
before the onset of albuminuria in diabetic mice (Franzén et al.,
2016). Functional MRI imaging techniques have also been
used to assess intrarenal oxygenation in humans, specifically
in diabetic patients. Inoue et al. demonstrated parenchymal
hypoxia and fibrosis in the renal cortex of CKD patients with
or without diabetes using BOLD MRI and diffusion-weighted
MRI, respectively (Inoue et al., 2011). Yin et al. reported reduced
cortical and medullary oxygenation in patients with type 2
1Diabetes-NIDDK. National Institute of Diabetes and Digestive and Kidney
Diseases. https://wwwniddknihgov/health-information/diabetes (accessed 2017).
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diabetes with nephropathy (Yin et al., 2012). Medullary hypoxia
was more prominent and present at earlier stages, with cortical
hypoxia becoming more apparent with worsening renal function
in diabetic patients. Pruijm studied the role renin-angiotensin
system (RAS) in renal oxygenation in early stage type 2 diabetic
patients with evidence of nephropathy (albuminuria and/or
hypertension) (Pruijm et al., 2013). Short-term RAS blockade
with ace-inhibitor or angiotension receptor blocker did not
increase renal tissue oxygenation. Although not specifically
examined in diabetes, animal studies have demonstrated an
increase renal oxygenation in both normal and remnant rat
kidney with RAS inhibition (Norman et al., 2003; Deng et al.,
2009). Short duration of RAS blockade or modest changes
in oxygenation not detected by BOLD MRI may explain the
discrepancy.
Other studies have examined renal oxygenation in diabetes
before any evidence of nephropathy and found similar baseline
renal oxygenation in cortical and medullary oxygenation in
diabetes compared to controls with BOLD MRI (Epstein et al.,
2002; Economides et al., 2004). However, remarkably in both
studies, patients with diabetes and even those at risk of diabetes
did not show any improvement in medullary oxygenation with
water diuresis, which was observed in healthy controls. This
suggests an early impairment of adaptive vasodilation in the
renal medulla in diabetes. Conversely, in a study in patients
with moderate to severe diabetic nephropathy, no differences
in cortical oxygenation but higher medullary oxygenation
compared to controls was observed (Wang et al., 2011). The
authors speculate that hypoxia noted in other studies in early
stages of diabetes may be due to high oxygen consumption
to support increased tubular reabsorption during the stage of
glomerular hyperfiltration. In their study, reduced GFR and the
associated decrease in tubular sodium reabsorption may result
in lower oxygen consumption and the apparent increase in
medullary oxygenation. The other possibility may be related to
the technical aspects of BOLD MRI measurements. BOLD MRI
measures tissue oxygenation indirectly by the changes in the
deoxyhemoglobin concentration in the capillaries supplying the
tissue. In advanced nephropathy, tissue fibrosis, reduction in
peritubular capillaries, and changes in tissue oxygen extraction
may lead to discrepancies between capillary deoxyhemoglobin
concentrations and tissue oxygenation. Technical aspects of
BOLD MRI and standard protocols for these measurements
have been extensively discussed in recent papers (Simon-
Zoula et al., 2006; Pruijm et al., 2016; Hirakawa et al., 2017).
Characteristics of the studies discussed is summarized in
Table 1.
RENAL OXYGENATION IN HYPERTENSION
AND HYPERTENSIVE CKD
Nearly 30% of adults in the United States hypertension according
to the National Health and Nutrition Examination Survey 2011–
2012 (Ostchega et al., 2008). Hypertension can affect each
renal compartment: vessels, glomeruli and tubulointerstitium
(Meyrier, 2015). Hypertensive nephropathy is the second only
to diabetic nephropathy as the most common cause of ESRD
in the US (Udani et al., 2011). Franz Volhard and Theodor
Fahr first introduced the term hypertensive nephrosclerosis
in 1918 (Meyrier, 2015) and several studies investigating the
pathophysiology and potential treatments have been published.
Over the last two decades, the role of renal oxygenation in
hypertensive nephrosclerosis has been investigated.
Welch et al. were the first to show that a lower tissue
oxygenation in both the cortex and medulla in angiotensin
II (Ang II)-infused or spontaneously hypertensive rats
(Welch et al., 2001, 2003). They further demonstrated that
oxygenation was restored with the administration of superoxide
dismutase mimetic, tempol, or an angiotensin receptor blocker,
candesartan. In spontaneously hypertensive rats, they also
observed a reduction in the ratio of tubular sodium transport
by oxygen consumption (TNa/QO2). In an acute hypertension
model with intravenous infusion of Ang II, reduced the
oxygenation in the cortex and isolated proximal tubules and
reduced TNa/QO2 was observed (Welch et al., 2005). All the
effects were reversed by tempol, demonstrating the role of
oxidative stress in this model. Recently, Emans et al. studied
the effects of Ang II on cortical pO2 by telemetry in conscious
rats (Emans et al., 2016). Using exogenous Ang II intravenously
or activated RAS in transgenic Cyp1a1Ren2 rats, they found
reduced renal cortical PO2 preceding the development of tissue
injury. Zhu et al. showed that chronic infusion of Ang II in
uninephrectomized rats increased tissue hypoxia as measured by
immunostaining with pimonidazole, as well as increased urinary
albumin excretion and collagen accumulation (Zhu et al., 2011).
The albuminuria and collagen accumulation was attenuated
by gene silencing of HIF-1α, linking upregulation of HIF-1α
with fibrosis in this model. In another model of hypertension,
renal neurogenic hypertension, induced by intrarenal injection
of phenol, was shown to renal increase HIF-1α expression
(Koeners et al., 2014). Interestingly, pretreatment with cobalt
chloride, known HIF-1α activator, attenuated the development
of hypertension and renal vasoconstriction.
Subtotal nephrectomy (STN), by uninephrectomy and partial
renal infarction in the contralateral kidney, is a well-established,
representative model of hypertensive CKD. Increased oxygen
consumption factored for sodium reabsorption or nephron
number has been observed in this model. Harris et al. observed
a threefold increase in oxygen consumption per nephron in
STN kidney at 4 weeks (Harris et al., 1988). Similar results
were observed by Nath et al. at 3 weeks in the STN kidney
(Nath et al., 1990). We have extensively studied the early
hemodynamic, transport and metabolic adaptations in the 1-
week STN kidney (Deng et al., 2009, 2010; Singh et al., 2009,
2012; Singh and Thomson, 2014). Amajor adaptation to nephron
loss in early STN is hyperfiltration in the remaining nephrons
(Singh et al., 2009). Hyperfiltration in the remaining nephrons
results in hyperreabsorption, and this is associated with increased
oxygen consumption. Indeed, we have previously reported the
high oxygen consumption factored for sodium reabsorption at
1 week after STN (Deng et al., 2009, 2010). We have also
demonstrated improved renal oxygenation with RAS blockade
and HIF-1α activation (Deng et al., 2009, 2010). Manotham
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TABLE 1 | Characteristics of studies in diabetes/diabetic CKD.
Species Types of
diabetes
Duration of
diabetes
Blood glucose
(mmol/l)
HbA1c (%) GFR
(ml/min)
eGFR
(ml/min/1.73m2)
Urinary protein
(mg/g uCr)
References
Rat STZ induced
diabetes
Up to 3 weeks 47.8 ± 14 N/A N/A Ries et al., 2003
14 days 20.9 ± 1.0 Edlund et al., 2009
Up to 4 weeks 24.5 ± 1.7 dos Santos et al., 2007
4 weeks 25.5 ± 1.2 1.14 ± 0.06 Palm et al., 2003
4 weeks 25.1 ± 0.6 1.01 ± 0.08 Palm et al., 2004
Up to 90 days 23.0 ± 1.5 ≤ 1.97 ± 0.1 Rosenberger et al.,
2008
Mouse Alloxan induced
diabetes
Up to 15 days 23.8 ± 1.7 N/A Negative Franzén et al., 2016
Human Diabetes* N/A N/A 7.0 ± 1.2 43.8 ± 27.7 980.0 ± 2229.1 Inoue et al., 2011
Type 2 diabetes 5.6 ± 5.5 years 7.8–11.1 7.7 ± 1.8 N/A 30-300 Economides et al.,
2004
7 ± 4.75 years 8.4 ± 1.0 7.4 ± 0.46 133 ± 7 Negative Epstein et al., 2002
7.85 ± 5.31
years
N/A N/A ≤88.45 ≤ 9989.55 Yin et al., 2012
±22.29 ±7421.91
11 ± 7 years 7.2 ± 3 7.8 ± 1.0 62 ± 22 Positive Pruijm et al., 2013
Diabetes* N/A N/A N/A ≤ 67 Positive Wang et al., 2011
CKD, chronic kidney disease; STZ, streptozotocin; HbA1c, hemoglobin A1c; GFR, glomerular filtration rate; eGFR, estimated GFR; uCr, urinary creatinine; N/A, information not available.
*Diabetes type not specified.
et al. showed evidence of tissue hypoxia in the STN kidney
as early as 4 days and more prominently at 7 days by using
pimonidazole immunostaining (Manotham et al., 2004). Tissue
hypoxia persisted until interstitial damage developed. Treatment
with Ang II blocker, olmesartan, prevented vascular changes and
ameliorated tubular hypoxia after nephron loss.
In terms of clinical evidence, Textor et al. showed that
African-American, hypertensive patients had elevated renal
medullary volumes and blood flow, and lower medullary
oxygenation compared to white hypertensive patients (Textor
et al., 2012). Pruijm et al. investigated the effect of sodium
intake on renal oxygenation in normotensive and hypertensive
subjects after 1 week of high sodium and 1 week of
low-sodium diet using BOLD MRI (Pruijm et al., 2010).
They found that low sodium intake was associated with an
increased renal medullary oxygenation but no changes in
renal cortical oxygenation in both normo- and hypertensive
individuals. In hypertensive patients, medullary oxygenation
correlated with 24-h sodium excretion but no correlation with
segmental renal sodium reabsorption was seen as observed
in normotensive group. They speculated that this may be
due to enhanced proximal sodium reabsorption and salt
sensitivity observed in hypertensive patients (Burnier et al.,
2006).
Schachiger et al. studied the role of RAS activation in
renal oxygenation in humans and showed an acute decrease
in cortical oxygenation by BOLD MRI after Ang II bolus
injection (Schachinger et al., 2006). Subsequently, another
study demonstrated a dose-dependent decrease of renal blood
flow accompanied by a minor decrease of oxygenation in the
cortex, not in the medulla with continuous Ang II infusion
in healthy humans (Bel et al., 2016). As discussed above,
parenchymal hypoxia and fibrosis in the renal cortex of CKD
patients using BOLD MRI and diffusion-weighted MRI has
been shown (Inoue et al., 2011). Other recent studies have
demonstrated increased renal oxygenation, particularly in the
renal medulla, with RAS blockade in healthy subjects and in
CKD patients (Stein et al., 2012; Siddiqi et al., 2014; Vink et al.,
2015). Characteristics of the studies discussed is summarized in
Table 2.
PATHOPHYSIOLOGY OF HYPOXIA IN CKD
Tubulointerstitial injury, which encompasses tubular atrophy
and interstitial fibrosis, is a hallmark of progressive CKD
regardless of its cause. Several studies have validated the
role of tissue hypoxia in the progression of kidney disease
(Kang et al., 2002; Nangaku, 2006; Heyman et al., 2008;
Singh et al., 2013). Compromised oxygen delivery due to
structural and functional changes impairing blood flow has
been demonstrated. Tubulointerstitial hypoxia in advanced
CKD can result from glomerular injury and interstitial fibrosis
(Heyman et al., 2008). Glomerulosclerosis decreases the blood
flow to downstream peritubular capillaries leading to insufficient
oxygen delivery. Interstitial fibrosis further impairs oxygen
delivery from the peritubular capillaries to the tubules. Recent
studies have demonstrated peritubular capillary dysfunction
as an important factor in the initiation of renal hypoxia
(Ohashi et al., 2000; Kang et al., 2002; Matsumoto et al.,
2004; Kawakami et al., 2014). Animal and human biopsy
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TABLE 2 | Characteristics of studies in hypertension/hypertensive CKD.
Species Model/type of
hypertension
Duration of
hypertension
GFR (ml/min) eGFR (ml/min/1.73 m2) Urinary protein
(mg/d)
References
Rat STN Up to 1 week N/A ≤ 51.5 ± 8.6 Manotham et al., 2004
1 week 0.53 ± 0.04 N/A Deng et al., 2010
8 days 0.85 ± 0.23 Singh et al., 2009
8 days 1.05 ± 0.20 (low salt)
0.95 ± 0.19 (high salt)
Singh and Thomson,
2014
3 weeks 0.66 ± 0.07 Nath et al., 1990
STN, unilateral
nephrectomy
1 week N/A Singh et al., 2012
Drug-induced 19 days No change compared to
control
Emans et al., 2016
Human Essential N/A 95 ± 24 120 ± 293 Textor et al., 2012
Essential N/A 106.9 ± 15.6 Negative Pruijm et al., 2010
Drug-induced 1 day N/A Negative Schachinger et al., 2006
Drug-induced 1 day 110 ± 18 N/A Bel et al., 2016
Essential and
secondary
N/A 30 ± 11 N/A Siddiqi et al., 2014
Essential N/A 75 2.2 mg/mmol,
albumin/creatinine
ratio
Vink et al., 2015
CKD, chronic kidney disease; STN, subtotal nephrectomy; GFR, glomerular filtration rate; eGFR, estimated GFR; N/A, information not available.
specimens in CKD have demonstrated that tubulointerstitial
injury is preceded by rarefaction of the peritubular capillaries
(Bohle et al., 1996; Choi et al., 2000; Babickova et al.,
2017).
The significance of these structural changes aside, early
hypoxia demonstrated in animal and human studies are likely
due to altered hemodynamics and metabolism. As discussed
above, alteration in renal oxygen consumption and tissue hypoxia
has been demonstrated in both diabetic and non-diabetic CKD
models prior to the development of structural changes (Ries
et al., 2003; Manotham et al., 2004; dos Santos et al., 2007; Deng
et al., 2009, 2010; Franzén et al., 2016). Moreover, kidney hypoxia
resulting from increased mitochondrial oxygen consumption
alone has been shown to induce kidney injury (Friederich-
Persson et al., 2013). Hence, understanding of the determinants
and regulation of renal oxygenation in early stages is valuable in
preventing subsequent tissue injury.
Chronic hypoxia causes tissue damage via various cytokine
and cell-signaling pathways including RAS, endothelin, plasmin
activator inhibitor-1, adhesion molecules and growth factors
(Heyman et al., 2008; Haase, 2013). Impaired nitric oxide
availability has also been implicated in the pathophysiology
of diabetic nephropathy (Palm et al., 2003; Prabhakar et al.,
2007) and hypertensive nephropathy (Welch et al., 2003;
Singh et al., 2008b; Deng et al., 2009). Nitric oxide can
increase renal oxygenation by improving oxygen delivery
via vasodilation and directly lowering oxygen consumption
(Evans and Fitzgerald, 2005; Singh et al., 2008b). HIF, a
key transcriptional regulator of cellular adaption to hypoxia,
has also received significant attention. It induces various
target genes that impact oxygen delivery via vasomotor
regulation and cellular oxygen consumption via several pathways
(Semenza, 2009). Downstream HIF target proteins include
inducible NOS, heme oxygenase-1, vascular endothelial growth
factor, glucose transproters, glycolytic enzymes as well as
proteins involved in cell proliferation and survival (Nangaku
and Eckardt, 2007; Gunaratnam and Bonventre, 2009). HIF
activation induces a glycolytic phenotype by upregulating GLUT
transporters to facilitate glucose entry and inducing glycolytic
enzymes (Semenza, 2009). HIF also has significant effects on
mitochondrial metabolism and improves efficiency of respiratory
chain proteins in hypoxia (Wheaton and Chandel, 2011). It
represses mitochondrial biogenesis and respiration (Papandreou
et al., 2006). It also induces mitochondrial autophagy as an
adaptive metabolic response in hypoxia (Zhang et al., 2008).
While HIF activation has been shown to be renoprotective
role in acute kidney injury, its effect in CKD are conflicting
(Nangaku and Eckardt, 2007; Haase, 2009). Pharmacological
HIF activation improved renal oxygenation, function and
morphology in streptozotocin-induced diabetic and in STN
rats (Deng et al., 2010; Li et al., 2015; Nordquist et al.,
2015). Other studies have also shown beneficial effects of
systemic HIF activation with different pharmacological agents
in experimental models characterized by hypoxia (Manotham
et al., 2004; Tanaka et al., 2005; Song et al., 2010; Yu
et al., 2012a). However, studies using genetic approaches have
yielded conflicting results. HIF-1α gene silencing or HIF-1α
knockout has been shown to attenuate albuminuria, collagen
accumulation and the development of tubulointerstitial fibrosis
(Welch et al., 2005; Wang et al., 2014). Proximal tubule specific
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FIGURE 1 | Schematic describing pathophysiology for the development of CKD in diabetes and hypertension (see text for details).
overexpression of HIF-1α under normoxic conditions increased
fibrosis while ablation ameliorated it (Higgins et al., 2007,
2008). Interestingly, the same group has subsequently shown
that global activation of HIF-1α in all tubules ameliorated
inflammation and fibrosis (Kobayashi et al., 2012). These results
suggest that the outcomes of HIF activation are cell-specific,
context-specific and timing-dependent in CKD (Yu et al.,
2012b).
Lastly, the role AMP-activated kinase in the metabolism
of diabetic and non-diabetic CKD is also receiving attention.
AMPK is a ubiquitously expressed, highly conserved, key energy
sensor and regulator of cellular metabolic activity (Hardie and
Ashford, 2014). It is activated by cellular stressor such as
nutrient deprivation, hypoxia or ischemia. AMPK facilitates
metabolic adaptation by triggering ATP producing pathways,
while inhibiting ATP consuming pathways (Gwinn et al., 2008).
It stimulates mitochondrial biogenesis and cellular autophagy as
survival mechanisms in low energy states (Steinberg and Kemp,
2009; Weinberg, 2011). Beneficial effects of AMPK activation
in diabetes and high-fat diet induced kidney disease has been
described (Lee et al., 2007; Hallows et al., 2010; Decleves et al.,
2011). AMPK activation has also been shown to improve oxygen
delivery and lower oxygen consumption and improve renal
function and histology in STN (Satriano et al., 2013). We have
also recently described the interactions between HIF and AMPK
pathways in the regulation of cellular hypoxia adaptation in STN
(Li et al., 2015). A schematic diagram incorporating some of the
above discussed aspects in the pathophysiology of development
of CKD is shown in Figure 1.
CONCLUSION
CKD is a major healthcare burden, associated with significant
comorbidities and progression to ESRD. Available therapies
for diabetic and non-diabetic CKD are inadequate in halting
or slowing the progression of disease. An increasing number
of experimental and clinical studies indicate that renal tissue
hypoxia, resulting from mismatch between oxygen delivery
and consumption is a major contributor to CKD progression.
Hence, it is imperative to understand the regulation of kidney
oxygenation in CKD to identify novel therapeutic targets.
Interventions to restore kidney tissue oxygenation has been
shown to be beneficial in animal models of CKD. Clinical studies
are limited and additional investigations into therapeutic targets
to improve renal oxygenation in different forms of CKD are
needed to improve clinical outcomes.
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